Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | CCR6 | P51684 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | NPY1R | P25929 | 1/20 | 0.48 |
| ▸ | NPY2R | P49146 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.48 |
| ▸ | GABRP | O00591 | 1/20 | 0.48 |
| ▸ | GABRD | O14764 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1733527 | 1.00 | SMN1; SMN2 (0.54) | SMN1; SMN2ALDH1A1CYP1A2MEN1KMT2A | |
| SCHEMBL6889759 | 0.87 | ALDH1A1 (0.61) | SMN1; SMN2ALDH1A1CYP1A2MEN1KMT2A | |
| SCHEMBL20606425 | 0.85 | SMN1; SMN2 (0.52) | SMN1; SMN2ALDH1A1CYP1A2MEN1KMT2A | |
| SCHEMBL163381 | 0.84 | SMN1; SMN2 (0.53) | SMN1; SMN2ALDH1A1CYP1A2MEN1KMT2A | |
| SCHEMBL7720682 | 0.84 | TDP1 (0.51) | ALDH1A1MEN1KMT2ALMNAMAPT | |
| SCHEMBL2222620 | 0.84 | SMN1; SMN2 (0.60) | SMN1; SMN2ALDH1A1CYP1A2MEN1KMT2A | |
| SCHEMBL3332188 | 0.84 | ALDH1A1 (0.50) | SMN1; SMN2ALDH1A1CYP1A2MEN1KMT2A | |
| SCHEMBL31389316 | 0.83 | KDM4E (0.54) | SMN1; SMN2ALDH1A1MEN1KMT2ALMNA | |
| SCHEMBL561686 | 0.83 | KDM4E (0.54) | SMN1; SMN2ALDH1A1MEN1KMT2ALMNA | |
| SCHEMBL13209979 | 0.83 | ALDH1A1 (0.59) | SMN1; SMN2ALDH1A1CYP1A2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119215104-A | Traditional Chinese medicine extract and application thereof in preparation of cell necrotic apoptosis inhibitor | 河南中医药大学 | 2024-12-31 | — | — | CN | claimed |
| US-20250275954-A1 | USE OF KYNURENIC ACID RESISTING HYPERURICEMIA AND STRUCTURAL ANALOG THEREOF IN PREPARATION OF XOD INHIBITOR | UNIV JIMEI (CN) | 2025-09-04 | — | — | US | disclosed |
| WO-2025107568-A1 | USE OF KYNURENIC ACID IN RESISTING HYPERURICEMIA AND STRUCTURAL ANALOG THEREOF IN PREPARING XOD INHIBITOR | 集美大学 | 2025-05-30 | — | — | WO | disclosed |
| CN-115887458-B | Application of 4-hydroxy-2-quinoline carboxylic acid ethyl ester in preparation of medicines or reagents for promoting liver cell proliferation | 集美大学 | 2025-01-07 | — | — | CN | disclosed |
| CN-119215104-A | Traditional Chinese medicine extract and application thereof in preparation of cell necrotic apoptosis inhibitor | 河南中医药大学 | 2024-12-31 | — | — | CN | disclosed |
| WO-2022214519-A1 | ANTIBACTERIAL COMPOUNDS | Janssen Sciences Ireland Unlimited Company (IE) | 2022-10-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250275954-A1 | USE OF KYNURENIC ACID RESISTING HYPERURICEMIA AND STRUCTURAL ANALOG THEREOF IN PREPARATION OF XOD INHIBITOR | XDH, DAO, KMO | SMN1; SMN2 4428/4885ALDH1A1 635/4885CYP1A2 326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.